All EDQM press releases
The chapter on Chemical Imaging (5.24) was adopted by the European Pharmacopoeia Commission at the end of November 2016. The Vibrational Spectroscopy and Analytical Data Modelling working party (VSADM) has produced the first such chapter to be included in any pharmacopoeia worldwide.
The Ph. Eur. Commission concludes its pilot phase for monographs for biotherapeutics still under patent
Since the approval of the first biological produced by recombinant DNA (rDNA) technology, recombinant human insulin, numerous biotherapeutics have received regulatory approval in Europe. European Pharmacopoeia (Ph. Eur.) monographs have been elaborated for many of these firstgeneration...
The European Pharmacopoeia Commission adopts the monograph on sodium pertechnetate (99mTc) (Accelerator-produced) injection (2891)
At its 156th Session the European Pharmacopoeia Commission adopted the monograph on Sodium pertechnetate (99mTc) (accelerator-produced) injection (2891).
The European Pharmacopoeia Commission adopts far-reaching texts implementing and promoting animal welfare
In accordance with the European Convention for the Protection of Vertebrate Animals used for Experimental and Other Scientific Purposes, the Ph. Eur. Commission is committed to the reduction of animal usage wherever possible in pharmacopoeial testing, and encourages those associated with its...
At its 156th session, the European Pharmacopoeia Commission approved the priorities for the three coming years, which are aimed at maintaining the scientific excellence, leading role and influence of the Ph. Eur. worldwide.